Published

Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Translational psychiatry
Date: 2025-10-31
Source: PubMed
DOI: 10.1038/s41398-025-03654-3
PubMed: 41173871

Authors

d'Andrea G Chiappini S Ciavoni L Tucci R Martino F Semeraro FM Di Battista D Mosca A Miuli A Di Carlo F Russo M Di Petta G Fornaro M Pettorruso M Sensi SL Martinotti G

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Brain Imaging Mechanism of Action Receptor Pharmacology Default Mode Network Aging Emotional Processing Clinical Trial Systematic Review Review Article Observational Study Treatment-Resistant Depression Systematic Review

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.2025-10-31

Related papers

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARASAIMSARA Journal · 2026-06-15 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 Psilocybin: Chemical Foundations and Emerging Therapeutic PotentialMini-Reviews in Medicinal Chemistry · 2026-06-01 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21